14C-Labelled oestradiol-17\g=b\ and progesterone (50 \g=m\Cieach) were injected i.v. into an adult female white rhinoceros and all urine and faeces collected separately over the next 4 days. The total recovery of injected label was 61%, 25% being present in the urine and 36% in the faeces. Of the radioactivity recovered, 69% was excreted on Day 2 of the collection period. Repeated extraction of samples obtained on Day 2 showed that, of the radioactivity in faeces, 92\m=.\4%was associated with unconjugated steroids whereas in the urine the proportion of conjugated and unconjugated steroids were similar (41\m=.\2% and 51\m=.\4%respectively). After phenolic separation of urinary steroids, HPLC followed by derivatization and recrystallization techniques identified progesterone as the major component of the unconjugated portion with 4-pregnen\x=req-\ 20\g=a\-ol-3-oneas the principal metabolite in the conjugated fraction. Pregnanediol was not present. Oestrone appeared to be the most abundant oestrogen metabolite with smaller but significant amounts of oestradiol-17\g=b\ and oestradiol-17\g=a\in the unconjugated and conjugated fractions respectively. Small amounts of progesterone were found in the faecal extract in which the radioactivity consisted mainly of oestradiol-17\g=a\ and oestradiol-17\g=b\. The results have established the major excreted metabolites of oestradiol-17\g=b\ and progesterone in the white rhinoceros and the development of more appropriate assay methods for monitoring ovarian function in African rhinoceroses should now be possible.
Introduction
Urinary hormone analysis has been increasingly applied as a non-invasive method for assessing reproductive function in mammals (Lasley, 1985;  Hodges, 1986; Hodges & Green, 1989) . Assays for urinary oestrone conjugates and pregnanediol-3-glucuronide have been used to monitor ovarian activity in a number of ungulates, including the Indian rhinoceros (Kassam & Lasley, 1981; Kasman et ai, 1986) . However, concentrations of urinary pregnanediol glucuronide and oestrone conjugates are low or non-detectable and show no cyclical changes corresponding to ovarian follicular or luteal activity in either the black (Ramsay et ai, 1987) or white African rhinoceroses.
Species differences in steroid hormone metabolism and excretion provide a possible explanation for this difference but no detailed information on metabolism of ovarian steroids is available for the African rhinoceros. The present study was therefore designed to investigate the metabolism and route of excretion of ovarian steroids in a female southern white rhinoceros by identifying the major excretory products of intravenously injected radiolabelled oestradiol-17ß and progesterone in both urine and faeces. *Present address: Deutsches Primatenzentrum GmbH, Kellnerweg 4, D-3400, Gottingen, West Germany.
Materials and Methods
Animal and housing The experimental animal was an adult female southern white rhinoceros (Ceratotherium simum simum), estimated age 31 years, housed indoors at Whipsnade Wild Animal Park, Zoological Society of London. Although it is not clear whether a white rhinoceros of this age would have functional ovaries, this animal was thought to be in reproductive quiescence since parturition 8 months previously.
Preparation and injection of radiolabel
The radiochemical purity of [4-14C] oestradiol-17ß (sp. act. 56mCi/mmol) and [4-14C] progesterone (sp. act. 56mCi/mmol) (Amersham International, UK) was established by thin-layer chromatography. Each label (50pCi) was evaporated under nitrogen and the residues redissolved separately in ethanol, then combined. A total volume of 1 ml including a rinse and containing 220 IO6 d.p.m. was removed and added to a further 1 ml ethanol containing 1 mg oestradiol-17ß and 10 mg progesterone (Sigma, Poole, Dorset, UK) as carriers. After adding 8 ml 30% (w/v) propylene glycol in water, the solution was filtered through a 0-22 pm (Millipore) filter unit before injection. On the morning of Day 1, the animal was anaesthetized with 1-25 ml etorphine hydrochloride (Immobilon: C-vet, Bury St Edmunds, Suffolk, UK), and the radiolabel injected into an ear vein. After 10 min the animal was revived with 2 ml diprenorphine hydrochloride (Revivon; C-vet).
Collection and storage of samples All urine and faeces were collected separately each day for 4 days (Days 1-4) following the injection of radiolabel on Day 1. To prevent contamination with urine, faeces were removed within 2 min of voiding. The total weight of faeces excreted during each day was determined and 1 kg portions were stored at -20°C. Urine was collected in a receptacle beneath the external outlet of the enclosure drain. The urine was mixed, the volume recorded and 1 litre portions were stored at -20°C, with sodium azide (final concentration 0-1%, w/v) as preservative.
Analysis of excreted material
The protocol for the analysis of urine and faeces is shown in Fig. 1 .
Distribution of radioactivity
Urine. Radioactivity in 1, 0-5 and 0-25 ml volumes of urine was counted, in triplicate, with 10 ml scintillation fluid (Scintran; BDH, Poole, Dorset, UK) for 10 min in a Beckman LS200 liquid scintillation counter. The efficiency of counting was 17-5% after quench corrections had been made by internal standardization with [14C]toluene and comparison to a quench curve constructed from 14C-quenched standards (G & G Chemical Services Ltd, Ascot. Berks, UK). The amount of radioactivity recovered per day was calculated.
Faeces. Radioactivity was extracted from faeces by first boiling with absolute ethanol (500 ml/250 g wet weight) for 10 min. The vegetable matter was strained and the residue squeezed before re-extraction by boiling for 20 min with 750 ml fresh absolute ethanol. Radioactivity in portions of 1,0-5 and 0-25 ml of each extract was counted. The extracts were combined and refluxed for 2 h at 70°C, then concentrated on a Bucchi rotary evaporator (Rotavapor-R) and the residue reconstituted in ethanol (200 ml). As approximately 83% ofthe total radioactivity recovered by extraction was present in the initial extract, with 17% in the second, it was concluded that the majority of extractable radiolabel had been extracted from the faeces and the residual vegetable matter was not analysed.
Separation of conjugated and unconjugated steroids
All subsequent analysis was carried out on the samples collected on Day 2 in which the majority of the injected radiolabel was recovered (see Table 1 ).
Urine. Unconjugated steroids were extracted from duplicate 50-ml portions of urine with 300 ml freshly distilled diethyl ether (BDH) and the aqueous fraction (containing the conjugated steroids) was removed. The ether was evaporated to dryness and the residue redissolved in ethanol (50 ml); radioactivity in duplicate 1-ml portions was counted. Procedural losses were monitored in separate extractions by the addition of trace amounts of [3H]progesterone, in which recoveries of 82-9 + 4-6% (mean + s.e.m., = 7) were obtained. By repeating the procedure with [3H]oestrone sulphate (Amersham International) and [3H]pregnanediol glucuronide (Dr P. Samarajeewa, University College, London), it was demonstrated that <3% ofthe conjugates were extracted by this procedure. Solvolysis (Hawkins & Oakey, 1974) , according to the method of Jacobsohn & Lieberman (1962) as modified by Eastman et a!. (1984) , is a stringent procedure known to hydrolyse most steroid conjugates including glucuronides (Carroll et ai, 1990) and was used to hydrolyse radiolabelled steroid conjugates in the urine. Volumes ofthe aqueous fraction (50 ml), after ether extraction as above, were diluted to 100 ml with phosphate-buffered saline, shaken with saturated sodium chloride solution (50 ml), 5 N-sulphuricacid (25 ml) and ethyl acetate (200 ml) and incubated at 37°C for 24 h. The solvent was removed and the aqueous phase re-extracted with 200 ml fresh ethyl acetate. The organic phases were pooled, washed with water and evaporated to dryness. The residue was re-dissolved in absolute ethanol (50 ml), and radioactivity in 1-ml portions ofthe solvent and the aqueous residue counted in duplicate. Residual radioactivity in the aqueous phase (5-2 + 2-41 %) was not analysed but could possibly represent 17-sulphated metabolites, unhydrolysed by solvolysis. The efficiency of the hydrolysis, monitored by repeating the procedure with phosphate buffer (50 ml) containing trace amounts of [3H]pregnanediol glucuronide, was 91-9 + 3-7% (n = 1). The hydrolysed conjugate fraction was retained.
Faeces. Ethanolic extracts of faeces were evaporated to dryness and the residue reconstituted in 10 ml phosphatebuffered saline and extracted with 100 ml freshly distilled diethyl ether. The ether was evaporated to dryness, the residue redissolved in 50 ml ethanol and radioactivity in 1-ml portions counted. Since 93% of the radioactivity recovered was present in the ether extract (associated with unconjugated steroids), further analysis was limited to this fraction.
Separation of phenolic and neutral steroids
Urine. Phenolic and neutral compounds in the hydrolysed conjugated and unconjugated fractions were separated by phenolic extraction according to a modification of the method of Brown (1955) . Ethanolic extracts were dried and redissolved in 10 ml petroleum ether (fraction 40-60°C; BDH). Oestrogens were removed by extracting 3 times with 5 ml 2 N-sodium hydroxide solution, and the ether washed with water. Aqueous phases were combined and reextracted with fresh petroleum ether (50 ml). Solvent extracts were combined to give the neutral fraction. The aqueous phase was adjusted to pH 7 and extracted 3 times with freshly distilled diethyl ether (75 ml) to form the phenolic fraction. Both fractions were evaporated to dryness and dissolved in absolute ethanol (10 ml) before radioactivity was counted. Similar separations (coefficient of variation of 7-9%) of phenolic and neutral compounds were obtained on 5 separate occasions. Ethanolic extracts were evaporated, the residue reconstituted in excess diethyl ether and dried over anhydrous sodium sulphate for 12 h.
Faeces. Ethanolic extracts were evaporated to dryness and the residue reconstituted in 10 ml petroleum ether before phenolic extraction.
Identification of steroids
High-performance liquid chromatography (HPLC). Separations were obtained using a Lichrosorb silica 60 column (250 4 mm, 10 pm particle size, MERK 50387). A linear gradient of 0-10% methanol in chloroform:»-hexane (50: 50, v/v) over 22 min at a flow rate of 2 ml/min was used to separate oestrogens (E. Mosti, personal coram.). Neutral steroids were separated using a linear gradient of 0-2% methanol in chloroform:n-hexane (30:70, v/v) over 30 min at a flow rate of 2 ml/min (Carroll et ai, 1990) . All extracts were dried, reconstituted in the appropriate initial solvent for injection onto the column with 3H-steroids as standards. Fractions (1 ml) were collected over 30 min and 3H and ,4C radioactivity was counted in each on a tricarb liquid scintillation analyser (Packard, Pangbourne, Sussex, UK;
1900CA). Using a spectrum analyser, calibrated in keV, the region 0-18-6 keV (3H Emax = 18-6 keV) was used to measure 3H radioactivity and the region 0-156 keV (14C Emal = 156 keV) was used to measure 14C radioactivity. By considering the composite spectrum obtained, corrections were made for 14C to 3H crossover by the scintillation analyser which also provided a 3H/14C ratio value for each sample.
HPLC elution fractions containing 14C-labelled neutral steroids co-eluting with 3H-labelled standards were divided into two portions. Steroids in one portion underwent derivatization, whilst those in the other portion were recrystallized as described below. 14C-labelled oestrogens underwent recrystallization only.
Derivatization. Labelled neutral steroids in HPLC fractions identified by co-elution with 3H standards were derivatized by selective reduction ofthe 3-oxo groups (Bush, 1961) . Briefly, HPLC fractions were dried down and the radiolabelled steroids dissolved in 9 ml methanol. A mixture of 2-5 M-sodium hydroxide (01 ml), methanol (3 ml) and 018 M-sodium borohydride in pyridine (2-8 ml) was added and the solution agitated with N2 for 10 min. After neutralization with hydrochloric acid, steroids were extracted with 200 ml diethyl ether. The ether was washed with dilute sodium hydroxide, dried over sodium sulphate and evaporated to dryness.
Steroids were reconstituted in initial chromatography solvent and two samples analysed using the HPLC systems described previously. Fractions were collected and counted for 3H and 14C radioactivity.
Recrystallization. The identity of 14C-labelled steroid metabolites co-eluting with 3H-steroids on HPLC was deter¬ mined by recrystallization to constant specific activity and 3H/14C ratio (Axelrod et ai, 1965) after the addition of 25 mg unlabelled carrier steroid. Steroids were dissolved in chloroform (0-5 ml) and 005 ml dispensed onto a preweighed planchette. Solvent was evaporated and the residue redissolved in warm acetone which was slowly evapor¬ ated whilst adding n-hexane in a drop-wise manner. The solution was transferred to 4°C and crystals grown for 24 h. After a short centrifugation the supernatent was removed, crystals redissolved in 0-5 ml chloroform and the process repeated. The mass of steroid and level of radioactivity in each planchette was determined, and the specific activity calculated. Recrystallization was not performed on the faecal steroids due to lack of sufficient radiolabel.
Results

Distribution of radiolabelled steroids
The amounts of urine and faeces excreted over the experimental period and the distribution of radioactivity are shown in Table 1 . Urinary and faecal excretion were low on Day 1, presumably whilst the animal recovered from the sedative. Of the administered label, 61% was recovered, 24-9% in urine and 35-6% in faeces; 90% ofthat excreted into the urine and 48% ofthat in faeces were recovered on Day 2.
On Day 2 similar proportions of radioactivity were associated with conjugated (41-2%) and unconjugated (51-4%) steroids in the urine, whilst 92-4% was associated with unconjugated steroids in the faeces. After phenolic extraction, the urine was found to contain a larger proportion of neutral (35%) than phenolic (12%) unconjugated metabolites, whereas a similar amount of each (21% and 18% respectively) was found in the conjugated fraction. Overall, progesterone metab¬ olites were predominant in the urine and oestrogen metabolites (67%) were predominant in the faeces.
Identification of radiolabelled steroids
Urine. The HPLC elution profiles of neutral steroids in urine (Fig. 2 ) showed single peaks of 14C-label in both the conjugated and unconjugated fractions which co-eluted with [3H]4-pregnen- 20a-ol-3-one and [3H]progesterone respectively. After derivatization, 3Hand 14C-radioactivity continued to elute in similar proportions with the same retention time (Fig. 2) . The identity of progesterone and 4-pregnen-20a-ol-3-one was subsequently confirmed when radiolabelled steroids were recrystallized to constant specific activity and 3H/14C ratio (Table 2) . No radioactivity was seen to co-elute with pregnanediol in the conjugated or unconjugated fraction (Fig. 2) .
The HPLC elution profile of phenolic steroids in the urine is shown in Fig. 3 . 14C-Radioactivity was found to co-elute with [3H]oestrone in the conjugated and unconjugated fractions, and with [3H]oestradiol-17ß in the unconjugated phenolic portion and [3H]oestradiol-17a in the conjugated portion. The identity of these oestrogens was confirmed by recrystallization (Table 2) . 
Discussion
The present study has established the identity of the major excretory products of exogenously administered oestradiol-17ß and progesterone in a female southern white rhinoceros.
During the sample collection period a total of 61% of the injected label was recovered in excreted urine and faeces. Since radioactivity was still present in excreted material (especially faeces) collected at the end of the study (Day 4), a longer period of sample collection would have resulted in a higher overall recovery of label and a higher proportion of radioactivity present in faeces. Nevertheless, 39% of the radioactivity recovered was excreted in the urine indicating that, whilst faecal excretion may predominate, the urinary pathway was a significant route of excretion for gonadal steroid metabolites.
Radioactivity in faeces was associated exclusively with steroids in the unconjugated form. The possibility exists that 3-sulphoconjugated products present in faeces were hydrolysed during the ethanol extraction procedure, and were therefore not detected. Whilst biliary steroids can exist in the conjugated form (Stoa & Skulstad, 1972) , it has been demonstrated from studies in the cow (Bamberg et ai, 1986) , sheep (Choi et ai, 1987) and horse (Bamberg et ai, 1984) that steroids are excreted into the faeces predominantly in the unconjugated form, probably after bacterial hydrolysis in the gut (Miyaziki et ai, 1972) .
Over 50% ofthe radioactivity in urine was unconjugated, in contrast to the findings of radiometabolism studies in other ungulates, e.g. the cow (Ivie et ai, 1986) and pig (Schomberg et ai, 1966) , in which <20% of excreted radiolabel was unconjugated. Furthermore, Kassam & Lasley (1981) demonstrated, using sequential hydrolysis, that more than 95% of urinary oestrogens were present as conjugates in the Indian rhinoceros, with a comparable figure being reported for the black 5ß-Pregnane-3u, 17u-diol Fig. 2 . HPLC elution profile of (a) conjugated and (b) unconjugated 14C-labelled neutral steroids (-) in urine and added 3H-labelled 4-pregnen-20a-ol-3-one (a,-) or progester¬ one (b,-). ·, Elution profiles of steroids in the form in which they are excreted in (b) and after hydrolysis in (a); , elution pattern of steroids after derivatization. rhinoceros (Ramsay et ai, 1987) . There are several factors which may have influenced the concen¬ tration of unconjugated steroids in the urine. Firstly, it is possible that, in the present experiment, conjugated steroids were hydrolysed during storage at -20QC despite the addition of a preserva¬ tive. However, this process does not appear to have led to generation of unconjugated 4-pregnen-20a-ol-3-one in urine. It should also be noted that 14C-labelled oestradiol-17ß may have been formed by the metabolism of injected progesterone. Furthermore, it is possible that the large dose of unlabelled steroids administered affected the pattern of metabolism.
In contrast to the small proportion of radioactivity associated with neutral steroids in the faeces, progestagens predominated in the urine, a distribution similar to that observed in other ungulates including the sheep (Stupnicki et ai, 1969) . The only urinary unconjugated neutral steroid was progesterone, whilst 4-pregnen-20a-ol-3-one accounted for more than 90% ofthe radiolabel in the conjugated fraction. Significantly, no conjugated pregnanediol was present in the urine. This finding is consistent with the observations of Ramsey et ai ( 1987) and Hindle et ai ( 1988) using HPLC and GC/MS analysis respectively of urine from non-pregnant black rhinoceroses, and is in marked contrast to observations made on the Indian species for which pregnanediol glucuronide is the major progesterone metabolite (Kasman et ai, 1986; Hindle et ai, 1988; Hodges & Green, 1989) . Although low levels of pregnanediol glucuronide immunoreactivity have been reported during the oestrous cycle of both the white and black rhinoceros , they do no reflect ovarian function and, in view of the present findings, are most probably due to measurement of cross-reacting substances.
In addition to confirming the absence of pregnanediol glucuronide, the present results suggest conjugated 4-pregnen-20a-ol-3-one as the major urinary progesterone metabolite. Serum concen¬ trations of 4-pregnen-20a-ol-3-one reflect corpus luteum function in the horse (van Rensburg & van Niekerk, 1968; Seren et ai, 1981) and non-specific measurement of urinary 4-pregnen-20aol-3-one has been used to monitor luteal function and pregnancy in various species, including the lion-tailed macaque (Shideler et ai, 1985) , killer whale (Walker et ai, 1988 ) and giant panda ( M onfort et ai, 1989) . No published data are available on the levels of urinary 4-pregnen-20a-ol-3-one in any ungulate, but its measurement should be informative in monitoring ovarian function in the white and possibly the black rhinoceros.
In contrast to the distribution of neutral steroids the amounts of radioactive phenolic steroids excreted into the urine and faeces were similar. Like other perissodactyls, including the tapir (Kasman et ai, 1985) , horse (Raeside & Liptrap, 1975) and Indian rhinoceros (Kassam & Lasley, 1981; Kasman et ai, 1986) , the white rhinoceros excretes conjugated oestrone as an abundant oestrogen metabolite in urine. The reason why measurement of urinary oestrone conjugates does not appear to reflect ovarian function in this species is unclear. The black rhinoceros excretes mainly oestrone glucuronide (Ramsay et ai, 1987) although, as in the present study, the position and configuration of the conjugation is not known and certain single and/or double conjugated oestrogens may exist which would not have been detected by the antisera used previously.
Oestradiol-17a was also an abundant conjugated metabolite of the injected oestradiol-17ß.
Formation of a 17a-epimer from [3H]oestradiol-17ß has been demonstrated in the dog (Siegel et ai, 1962) , and measurement of oestradiol-17a by immunoassay has been shown to reflect ovarian function accurately in the cow (Dobson & Dean, 1974) and ruffed lemur (Shideler et ai, 1983 ). Urinary oestrone conjugates have not previously been shown to reflect ovarian function in the white rhinoceros, but measurement of oestradiol-17a may be more informative.
Over 70% of radioactivity excreted into the faeces in this study was almost exclusively associated with oestrogenic steroids, and measurement of faecal oestrogens either collectively as total oestrogens (Mosti et ai, 1987) or individually as oestradiol-17a (Mosti et ai, 1984) may be useful in determining reproductive status. Such methods have been used for pregnancy diagnosis in a variety of species, including ungulates (Safar-Hermann et ai, 1987) , and may also be applicable to the detection of pregnancy in the white rhinoceros.
In conclusion, this study has shown that differences in steroid hormone metabolism and excretion exist between the African and Indian species of rhinoceros. Although the results obtained from this study require confirmation by analysis ofurine collected during natural cycles, the identification ofthe major metabolites of injected oestradiol-17ß and progesterone as described here should form the basis for the development of improved assay methods for monitoring ovarian function in the African rhinoceroses. Such methods are urgently needed to assist the captive management and breeding of these highly endangered species.
